The first day of the general investor subscription for DTS's IPO has concluded. The subscription runs for two days, and investors are focused on the number of subscriptions received on the first day, the shares allocated equally by securities firm, and the proportional competition ratios.

■ Day One Subscription Closes...Daishin Securities Records 83,209 Subscriptions

DTS's day one subscription schedule ended at 4 p.m. on the 13th. General subscriptions are being conducted through Daishin Securities and Eugene Investment & Securities.

Subscriptions received that day totaled 83,209 at Daishin Securities and 9,008 at Eugene Investment & Securities. The resulting equal allocation shares were tallied at 3.01 shares for Daishin Securities and 3.09 shares for Eugene Investment & Securities. The proportional competition ratios recorded 60.50 to 1 for Daishin Securities and 3.09 to 1 for Eugene Investment & Securities.

As subscriptions are being conducted through the two securities firms, investors are also paying attention to the number of subscriptions and allocable shares at each firm.

■ Institutional Demand Forecast Competition Ratio Recorded at 983.98 to 1

Previously, DTS recorded a competition ratio of 983.98 to 1 in its demand forecast for institutional investors. With the general investor subscription schedule following the institutional demand forecast, attention is also on how the competition ratio will change on the second day after the first day.

■ Final Allocation Results Confirmed After Close...May Differ from Day One Figures

On the final day of the subscription, the equal allocation shares and proportional competition ratio may change depending on the additional subscriptions received and the size of deposits. Therefore, investors should keep in mind that first-day figures may differ from the final allocation results.

With DTS having completed its first day of subscription, how investor participation will trend through the final subscription close remains to be seen.

[※ This article is for investment reference purposes only and does not constitute a recommendation to buy or sell any specific stock. Investment decisions and any resulting responsibility rest with the investor.]